The Impact of Human Immunodeficiency Virus Exposure on Respiratory Syncytial Virus-associated Severe Respiratory Illness in South African Infants, 2011-2016.


Journal

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
ISSN: 1537-6591
Titre abrégé: Clin Infect Dis
Pays: United States
ID NLM: 9203213

Informations de publication

Date de publication:
27 11 2019
Historique:
received: 21 12 2018
accepted: 04 04 2019
pubmed: 10 4 2019
medline: 20 9 2020
entrez: 10 4 2019
Statut: ppublish

Résumé

From 2011 through 2016, we conducted surveillance for severe respiratory illness in infants. Human immunodeficiency virus exposure significantly increased the risk of respiratory syncytial virus (RSV)-associated hospitalization in infants aged <5 months. More than 60% of RSV-associated hospitalizations occurred in the first 4 months of life and may be preventable through maternal vaccination or birth-dose monoclonal antibody.

Identifiants

pubmed: 30963178
pii: 5432318
doi: 10.1093/cid/ciz288
pmc: PMC6934254
mid: NIHMS1063360
doi:

Types de publication

Historical Article Journal Article Research Support, U.S. Gov't, P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

2208-2211

Subventions

Organisme : Intramural CDC HHS
ID : CC999999
Pays : United States
Organisme : NCIRD CDC HHS
ID : U01 IP001048
Pays : United States
Organisme : ACL HHS
ID : U01IP001048
Pays : United States

Informations de copyright

Published by Oxford University Press for the Infectious Diseases Society of America 2019.

Références

Pediatrics. 2016 Apr;137(4):null
pubmed: 27025960
J Infect Dis. 2013 Dec 15;208 Suppl 3:S217-26
pubmed: 24265481
PLoS One. 2014 Aug 18;9(8):e105543
pubmed: 25133576
Clin Infect Dis. 2008 Jan 1;46(1):50-7
pubmed: 18171213
Vaccine. 2017 Oct 27;35(45):6172-6179
pubmed: 28967522
BMC Infect Dis. 2014 Dec 16;14:694
pubmed: 25510622
Lancet. 2017 Sep 2;390(10098):946-958
pubmed: 28689664
Clin Infect Dis. 2015 Oct 15;61(8):1217-24
pubmed: 26245665
Lancet. 2010 May 1;375(9725):1545-55
pubmed: 20399493
Emerg Infect Dis. 2017 Jul;23(7):1124-1132
pubmed: 28628462
J Infect Dis. 2012 Dec 15;206 Suppl 1:S159-65
pubmed: 23169964
Clin Infect Dis. 2019 Feb 15;68(5):773-780
pubmed: 29961814
Pediatr Infect Dis J. 2018 Sep;37(9):886-892
pubmed: 29373476

Auteurs

Meredith L McMorrow (ML)

Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia.
Influenza Program, Centers for Disease Control and Prevention, Pretoria, South Africa.
US Public Health Service, Rockville, Maryland.

Stefano Tempia (S)

Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia.
Influenza Program, Centers for Disease Control and Prevention, Pretoria, South Africa.
Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa.
Mass Genics, Duluth, Georgia.

Sibongile Walaza (S)

Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa.
School of Public Health, Faculty of Health Sciences, Johannesburg, South Africa.

Florette K Treurnicht (FK)

Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa.
School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.

Jocelyn Moyes (J)

Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa.
School of Public Health, Faculty of Health Sciences, Johannesburg, South Africa.

Adam L Cohen (AL)

Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia.
Influenza Program, Centers for Disease Control and Prevention, Pretoria, South Africa.
US Public Health Service, Rockville, Maryland.
Expanded Programme on Immunization, Department of Immunization, Vaccines and Biological, World Health Organization, Geneva.

Marthi Pretorius (M)

Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa.
Technical Research and Development, Novartis Pharma AG, Basel, Switzerland.

Orienka Hellferscee (O)

Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa.
School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.

Nicole Wolter (N)

Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa.
School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.

Anne von Gottberg (A)

Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa.
School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.

Arthemon Nguweneza (A)

Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa.

Johanna M McAnerney (JM)

Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa.

Fathima Naby (F)

Department of Paediatrics, Pietermaritzburg Metropolitan Hospitals, University of KwaZulu-Natal.

Omphile Mekgoe (O)

Department of Paediatrics, Klerksdorp Hospital, North West Province.

Marietjie Venter (M)

Emerging Vectorborne and Respiratory Virus Program, Center for Viral Zoonoses, Department of Medical Virology, University of Pretoria.

Shabir A Madhi (SA)

Medical Research Council, Respiratory and Meningeal Pathogens Research Unit, Johannesburg, South Africa.
Department of Science and Technology/National Research Foundation: Vaccine Preventable Diseases, University of the Witwatersrand, Johannesburg, South Africa.

Cheryl Cohen (C)

Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa.
School of Public Health, Faculty of Health Sciences, Johannesburg, South Africa.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH